[The development of resistance must be monitored--gonococci as an example]

Tidsskr Nor Laegeforen. 2014 Mar 11;134(5):507-8. doi: 10.4045/tidsskr.14.0033.
[Article in Norwegian]
No abstract available

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Drug Resistance, Bacterial*
  • Drug Utilization / standards
  • Humans
  • Neisseria gonorrhoeae / drug effects*
  • Sentinel Surveillance

Substances

  • Anti-Bacterial Agents